Thursday, September 08, 2011

Layoffs Expected in Dendreon's Cost-Cutting Plan - Sept. 8, 2011

Having trouble viewing this email? View in Browser.
BioSpace GenePool
   Thursday, September 08, 2011 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

At Aptuit's MHRA certified and FDA inspected multi-purpose manufacturing site in Oxford, England, we can produce highly potent compounds at commercial scale in accordance with the highest safety and quality standards.

Please click here for more information.
Top Stories 
•  Layoffs Expected in Dendreon Corporation (DNDN)'s Cost-Cutting Plan More...
•  Pfizer Inc. (PFE)'s Arthritis Pill Tofacitinib Matches Abbott Laboratories (ABT)'s Humira in Final Studies More...
•  Johnson & Johnson (JNJ) and Bayer HealthCare (BAY) Bloodthinner Faces FDA Panel Today More...
•  Iroko Pharmaceuticals to Create 150 New Jobs, Space at Philadelphia Navy Yard More...
•  Thermo Fisher Scientific (TMO) Adding 110 Jobs in Asheville, Moving Jobs Out of NH More...
•  Elusys Therapeutics, Inc. Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection More...
•  Genzyme Corporation (GENZ) Apologizes for Fabrazyme Screw Up More...
•  Ranbaxy Laboratories (RANBAXY.BO) Climbs on Lipitor Launch Buzz; Stock Rises +20.10 (4.13%) @ 10:30AM EDT More...

More Top News
Don't Miss This

Advancing Oncology. Changing Medicine.

Crown Bioscience Inc. is a US-based oncology service company committed to advancing anti-cancer therapeutics through the preclinical and drug development stages. Our multi-disciplinary team of experts, located in two research campuses in Beijing and Shanghai, provides an integrated service solution from your idea to an enabling IND, including: preclinical, translational and clinical capabilities. Crown Bio offers a full range of predictive models; such as HuPrime™ xenografts , OmniPanel™ cell based screens, and SnapShot™ translational research services to provide data to help you select the development candidate with the highest chance of success.

To learn more about our unique portfolio and breadth of services, visit www.crownbio.com or call us at 603-686-9330.
Featured Stories
•  Shire plc CEO: Pharma Must "Wake Up" to Price Reality More...
•  Potatoes Reduce Blood Pressure in People With Obesity and High Blood Pressure, University of Scranton Study More...
•  Can Carbon Dioxide Help With Nasal Allergies? More...
•  University of Southern California Scientists Identify Key Protein Linked To Acute Liver Failure More...
•  Neurosurgeons Use Adult Stem Cells to Grow Neck Vertebrae, University of California, Davis (UCD) Study More...
•  Why Kidney Failure Risk 4x Higher for Blacks, Emory University Study More...
•  Diabetes: New Drug Target That Stimulates Beta Cell Growth Identified, Swiss Federal Institute of Technology Study More...
•  Plenty of Pals and Playtime May Turn Bad Fat Into Good, Ohio State University Medical Center Study More...
Tower: Facebook

 
More Featured News
Event of the day

IBC's BioProcess International Conference & Exhibition
October 31 - November 4, 2011 - Long Beach, California
Event Website

Download the 2011 BioProcess International brochure and see why this is YOUR must attend event for 2011. Download your PDF here.

You will see the 2011 program, features a stellar line up keynote presentations including, the US FDA, EMA, Pfizer, Merck and more. Plus, there are over 50 presentations with new, previously unpublished data, and new topic coverage areas including antibody drug conjugates, viral clearance and managing global manufacturing facilities and partners.

Register by September 9 and you will save $200 off the standard conference rates with priority code B11171BSEODS. Exhibit hall & keynote passes are now available. Mention priority code B11171BSEODS and the fee will be waived. All passes subject to approval.

Register here today or call 800-390-4078.
Latest Market Insight

The Stem Cell Market Outlook

• Identify potential growth markets with sales forecasts by indication and expected timing of market entry.
• Compare the different business models for stem cell therapies.
• Evaluate which novel products offer the greatest potential clinical advances over the next several years and why.
• Assess potential clinical advances and how they address current unmet needs.

Click Here for More Information


Featured Free Resource

Nature Methods

Nature Methods provides techniques for life scientists and chemists. It is a print and online publication dedicated to publishing novel methods together with significant advances to tried and tested techniques allowing researchers to perform faster, better and more efficient experimental research.

Request Now!
Top Jobs
Genetown and Bio NC (Billerica, Massachusetts and Durham, North Carolina)

SPARKS
Clinical Trial Specialists
Act as an independent Coordinator on projects both locally and remotely. Apply knowledge across multiple projects. Contribute to the development and implementation of Study Start Up (SSU) related processes, tools, and training materials as well as provide training as needed.

Biotech Bay (Foster City, California)

Gilead Sciences
Senior Director Biomarker Core
Lead a small group of scientists to successfully integrate biomarker strategies and biomarker assays initiated in discovery and translated through to clinical development programs in multiple therapeutic areas.

BioMidwest (New Prague, Minnesota)

Electromed, Inc.
Chief Financial Officer
Responsible for all accounting practices, including the timely completion of the companys accounting and financial reporting. He/She proposes financial strategy, planning, and forecasts in consultation with company officers and managers.

Biotech Beach (Los Angeles, California)

Baxter International, Inc.
Manager, Engineering
Manage a controls system engineering staff and coordinate resources to meet the business needs of all manufacturing and facilities areas. Create and manage a vision for the process control group and systems that aligns with the organization's strategic plan.

BioCapital (Frederick, Maryland)

MedImmune, LLC
QA Specialist III - ATS
Responsible for assuring the quality of licensed products manufactured at MedImmune and contractors. Supports the evaluation and disposition of labeling, raw materials, intermediates and finished products through timely compliance evaluation of batch records, laboratory results and other cGMP documents.

Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center!
BioSpace Career Fairs

Biotech Pharm Country Career Fair

Biotech Beach Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Biotech Beach Career Fair, San Diego, CA September 22, 2011
BioMidwest Career Fair, Chicago, IL October 4, 2011
Pharm Country Career Fair, Bridgewater, NJ October 5, 2011
Biotech Bay Career Fair, Burlingame, CA October 11, 2011
Bio NC Career Fair, Durham, NC October 20, 2011
BioCapital Beach Career Fair, Bethesda, MD November 1, 2011
Genetown Career Fair, Cambridge, MA November 7, 2011

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Company of the day

Amylin Pharmaceuticals, Inc.
9360 Towne Centre Drive
San Diego, California 92121 U.S.A.
Phone: 858-552-2200 Fax: 858-552-2212

Amylin Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection.

More Company Profiles
Free Resources
FREE Subscription to Clinical Laboratory International (CLI)

Clinical Laboratory International (CLI) is the leading clinical lab magazine internationally and is crammed with information of direct relevance to everyone working in clinical and blood bank laboratories.
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

BioSpace Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
BioSpace Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the BioSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu

BioSpace.com - Life. Science. Community.
Legal Notice

• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2011 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.



No comments: